Vimarsana
Biggest News Aggregation in the World

Page 5 - Aktx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aktx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aktx Today - Breaking & Trending Today

Akari Therapeutics Names Wendy DiCicco Interim Finance Chief - Vimarsana News

Akari Therapeutics Names Wendy DiCicco Interim Finance Chief

By Ben Glickman Akari Therapeutics said Wednesday it has named Wendy DiCicco interim chief financial officer. The London-based biotechnology company said...

Akari Therapeutics Shares Rise 22% After Nomacopan's Positive Orphan Drug Opinion in Europe - Vimarsana News

Akari Therapeutics Shares Rise 22% After Nomacopan's Positive Orphan Drug Opinion in Europe

By Ben Glickman Shares of Akari Therapeutics rose Thursday after the company said it had received a positive opinion on a drug treatment's application for...

Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com - Vimarsana News

Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report released on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance NASDAQ:AKTX opened at $0.16 on Friday. The stock has a 50-day simple moving average of $0.18 and a two-hundred day simple […]

StockNews.com Initiates Coverage on Akari Therapeutics (NASDAQ:AKTX) - Vimarsana News

StockNews.com Initiates Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a research note issued to investors on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 0.6 % Shares of NASDAQ:AKTX opened at $0.16 on Thursday. Akari Therapeutics has a 12-month low of $0.14 and […]

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX) - Vimarsana News

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Rating) in a report released on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance AKTX opened at $0.16 on Thursday. Akari Therapeutics has a 1-year low of $0.14 and a 1-year high of $1.61. The stock […]